In this podcast, the Milken Institute interviews Tal Zaks, the Chief Medical Officer of Moderna Therapeutics to discuss the development of their COVID-19 vaccine candidate using messenger RNA (mRNA) technology. It took them only 63 days from the time the virus was sequenced until the vaccine candidate began human clinical trials. It is hoped that this new technology may also be adapted as possible treatments for other genetic diseases.
Listen to the podcast here